52% and 66% death reduction for molnupiravir and nirmatrelvir–ritonavir users among inpatients with COVID-19
Peering into single cells reveals key processes in acute kidney injury
5 October 2022Voice screening app delivers rapid results for Parkinson’s and severe COVID
5 October 202252% and 66% death reduction for molnupiravir and nirmatrelvir–ritonavir users among inpatients with COVID-19
A research team including members from the Department of Pharmacology and Pharmacy, School of Public Health, Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed), and Laboratory of Data Discovery for Health (D²4H) have conducted one of the first real-world studies to explore the inpatient use of oral antivirals during a pandemic wave dominated by the SARS-CoV-2 omicron variant.
